Thymosin Beta-4 is the naturally occurring protein that TB-500 is derived from, involved in cell migration, tissue repair and reducing inflammation throughout the body. It is being studied in legitimate research settings for specific conditions, distinct from the unregulated peptide products sold online under similar names.
Genuine scientific interest exists in its biological role, and it has been studied in early-phase clinical research for specific conditions such as certain eye and heart conditions. This differs meaningfully from the online research chemical market, where sourcing and purity are not controlled in the same way as a clinical trial.
In legitimate research settings, it is administered under controlled clinical protocols. Products purchased online outside that context carry the same unregulated risks as other research chemicals: unverified purity, unknown dosing, and no established human safety profile.
Legal and research status: this peptide is typically sold as a research chemical, labelled not for human consumption, and is not an approved medicine or supplement in the UK, EU or US. Buying it for personal use sits in a legal grey area, and product purity and dosing are not independently verified or regulated. The legitimate clinical research on Thymosin Beta-4 does not translate to safety or efficacy for an unregulated product bought online. There is no approved consumer use.
Sold online as a research chemical, priced per vial, distinct from investigational drug pricing in formal clinical trials.
Early-phase clinical research on Thymosin Beta-4 for specific medical indications. Educational information only. Not an approved medicine for general use.